Ligand Pharmaceuticals | LGND - DŁUG





DŁUG Zmiana Data
Agenus USD 35.54M 2.34M 2025-03
Amgen USD 54.59B 1.62B 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 366.28M 13.25M 2025-09
Baxter International USD 9.71B 13M 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Enanta Pharmaceuticals USD 1.35M 0 2024-12
Enviri Corporation USD 1.44B 3.08M 2024-12
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
Glaxosmithkline GBP 17.75B 396M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 727.89M 163.33M 2025-12
Intrexon USD 0 13.82M 2024-06
Ionis Pharmaceuticals USD 2.33B 1.1B 2025-12
Karyopharm Therapeutics USD 299.23M 35.14M 2025-12
Ligand Pharmaceuticals USD 451M 445.26M 2025-09
MacroGenics USD 37.01M 238K 2025-09
Merck USD 41.37B 5.97B 2025-09
Pacira USD 372.19M 4.53M 2025-12
Pfizer USD 60.85B 78M 2025-09
Rigel Pharmaceuticals USD 59.69M 90K 2024-06
Sangamo BioSciences USD 0 0 2022-06
Veracyte USD 40.45M 10.19M 2025-09